Ascendis Pharma A/S Increase Decrease Through Changes In Fair Values Liabilities Arising From Financing Activities
Ascendis Pharma A/S (ASND) reported Increase Decrease Through Changes In Fair Values Liabilities Arising From Financing Activities of -EUR 142.47 million for the 12-month period ending 2022-12-31, per its 20-F filed 2024-02-07.
Discontinued › Cash Flow › Operating Activities
ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities · last filed 2024-02-07
| Period end | Increase Decrease Through Changes In Fair Values Liabilities Arising From Financing Activities 12 month |
|---|---|
| 2022-12-31 | -142.47M EUR 20-F · filed 2024-02-07 |